September 1, 2020

COVID-19 Daily – Peer-Reviewed & Preprint Studies, Clinical Trials, Patents, and Other Business Information

DUBLIN, Sept. 1, 2020 /PRNewswire/ — The “COVID-19 Daily” newsletter has been added to ResearchAndMarkets.com’s offering.
COVID-19 Daily covers research developments…

DUBLIN, Sept. 1, 2020 /PRNewswire/ — The “COVID-19 Daily” newsletter has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

COVID-19 Daily covers research developments from around the world on the novel coronavirus. The research news coverage includes both peer-reviewed as well as preprint (not yet formally reviewed) studies, in addition to clinical trials, patents, and other business information.



An annual subscription includes new issues Monday through Friday, 52 weeks out of the year.



For over 30 years, the analyst has monitored and reported on the world’s emerging research and discoveries every day. With decades of reporting experience, we understand that great journalism demands transparent sourcing and journalistic integrity. Original content is reported from sources of unparalleled depth according to the highest standards of journalism.

For more information about this newsletter visit https://www.researchandmarkets.com/r/ivupmg

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com



For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/covid-19-daily—peer-reviewed–preprint-studies-clinical-trials-patents-and-other-business-information-301121986.html

SOURCE Research and Markets